DK1294372T3 - Törpulverformulering der omdanner racecadotril - Google Patents

Törpulverformulering der omdanner racecadotril

Info

Publication number
DK1294372T3
DK1294372T3 DK01969310T DK01969310T DK1294372T3 DK 1294372 T3 DK1294372 T3 DK 1294372T3 DK 01969310 T DK01969310 T DK 01969310T DK 01969310 T DK01969310 T DK 01969310T DK 1294372 T3 DK1294372 T3 DK 1294372T3
Authority
DK
Denmark
Prior art keywords
dry powder
racecadotril
transforms
powder formulation
formulation
Prior art date
Application number
DK01969310T
Other languages
English (en)
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Application granted granted Critical
Publication of DK1294372T3 publication Critical patent/DK1294372T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01969310T 2000-06-23 2001-06-22 Törpulverformulering der omdanner racecadotril DK1294372T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00401799 2000-06-23
PCT/EP2001/007086 WO2001097801A2 (en) 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril

Publications (1)

Publication Number Publication Date
DK1294372T3 true DK1294372T3 (da) 2005-09-19

Family

ID=8173739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969310T DK1294372T3 (da) 2000-06-23 2001-06-22 Törpulverformulering der omdanner racecadotril

Country Status (13)

Country Link
US (1) US6919093B2 (da)
EP (1) EP1294372B1 (da)
CN (2) CN102151247A (da)
AT (1) ATE301999T1 (da)
AU (1) AU2001289606A1 (da)
BG (1) BG66212B1 (da)
CA (1) CA2415957C (da)
CZ (1) CZ299591B6 (da)
DE (1) DE60112756T2 (da)
DK (1) DK1294372T3 (da)
ES (1) ES2247163T3 (da)
SK (1) SK287819B6 (da)
WO (1) WO2001097801A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
EP2462922A1 (en) 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
WO2013057570A2 (en) * 2011-10-18 2013-04-25 Purdue Pharma L.P. Acrylic polymer formulations
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
EP2866802B1 (en) * 2012-06-28 2016-07-27 Johnson & Johnson Consumer Inc. Racecadotril liquid compositions
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
US9114171B2 (en) 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
MA39009A (fr) 2014-03-10 2015-09-16 Galenicum Health Sl Compositions pharmaceutiques comprenant un agent actif
ES2555484T1 (es) * 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
WO2018115130A1 (en) 2016-12-23 2018-06-28 Hermes Arzneimittel Gmbh Oral pharmaceutical composition with improved taste-masking properties
KR102195776B1 (ko) * 2017-03-06 2020-12-29 아테나 파르마쎄티크 에스에이에스 라세카도트릴을 포함하는 약학 조성물 및 이를 제조하는 방법
CN109589310A (zh) * 2017-10-01 2019-04-09 北京万全德众医药生物技术有限公司 消旋卡多曲干混悬剂及其制备方法
GB2586201B (en) * 2019-05-14 2023-05-24 Orbit Pharmaceuticals A stable powder formulation of racecadotril
EP4056171A1 (en) 2021-03-12 2022-09-14 Athena Pharmaceutiques SAS Taste masked racecadotril tablet composition and process for preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1997033571A1 (fr) * 1996-03-14 1997-09-18 Shionogi & Co., Ltd. Preparation d'ecadotril a microdispersion et liberation rapides
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations

Also Published As

Publication number Publication date
CN102151247A (zh) 2011-08-17
CZ2003185A3 (cs) 2003-05-14
EP1294372B1 (en) 2005-08-17
SK762003A3 (en) 2003-07-01
AU2001289606A1 (en) 2002-01-02
BG66212B1 (bg) 2012-05-31
CN1635884A (zh) 2005-07-06
US20030166718A1 (en) 2003-09-04
WO2001097801A2 (en) 2001-12-27
CA2415957A1 (en) 2001-12-27
US6919093B2 (en) 2005-07-19
CA2415957C (en) 2010-08-10
EP1294372A2 (en) 2003-03-26
CZ299591B6 (cs) 2008-09-10
ES2247163T3 (es) 2006-03-01
DE60112756T2 (de) 2006-06-08
ATE301999T1 (de) 2005-09-15
WO2001097801A3 (en) 2002-09-12
SK287819B6 (sk) 2011-11-04
BG107481A (bg) 2003-09-30
DE60112756D1 (de) 2005-09-22

Similar Documents

Publication Publication Date Title
DK1294372T3 (da) Törpulverformulering der omdanner racecadotril
DE69907977D1 (de) Pyrrolobenzodiazepine
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
NO20024099L (no) Lavdose entecavir-formulering og anvendelse
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DK1397174T3 (da) Pulverformulerings-desintegrationssystem og tørpulverinhalatorer
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
TR199900505T2 (da)
BR0210101A (pt) Combinações antineoplásticas
ATE275143T1 (de) Verbindungen
NO20032597D0 (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
EP1303520A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
PT1263421E (pt) Avasimibe, o inibidor duplo da sintese de ester de colesterilo e de ester ceroso, para o tratamento de disturbios da glandula sebacea
DK1049468T3 (da) Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
IL152989A0 (en) Use of riluzole or its salts for preventing and treating ?noleukodystrophy
ECSP972253A (es) Composicion farmaceutica: nueva formulacion y su uso en el tratamiento y/o profilaxis de ciertos trastornos
FI20000549A0 (fi) Sexi-hoito ja hierontapöytä
IL137148A0 (en) Compounds and pharmaceutical compositions comprising same and their use in the field of apoptosis or cogulation